Foreign participants at the 16th Asia Pharma Expo foresee a bright future for Bangladesh’s pharmaceutical industry, given its ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Pharmaceutical manufacturing is a key component of Purdue’s One Health initiative, which advances knowledge and innovation related to animal, human and environmental health and well-being through ...

There is a need to focus on innovation, new drug development and biopharmaceuticals as spending on research and development ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) in Q4 CY2024, with sales flat year on year at $594 million. Its ...

Our pharma industry is known for generic product development ... This realizes an urgent need for the development and promotion of cancer-centric research. Government funding and private sector ...

The growth of the cell culture media market is driven by rising demand for biopharmaceuticals, vaccines, and cell-based therapies, fueled by advancements in biotechnology and life sciences research.